What will Boston Pharmaceuticals CEO Sophie Kornowski do now that the company is selling off its pipeline and winding down ...

Nazara Technologies' subsidiary Nodwin shareholding falls, Dixon's agreements with Chinese firms scrutinised, LT Foods opens ...

Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing preclin | Sanofi has struck a deal to buy Vicebio ...

Vicebio, a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral infections, has ...

Using patient-derived B cells, Kling-Select facilitates the rapid detection of new antibodies and preserved viral epitopes.

Paris-based drugmaker Sanofi is acquiring U,K,-based Vicebio to gain its molecular clamp vaccine technology, with the total ...

Sanofi is investing $25 million in the biotech, taking up its option on a third program and agreeing to sponsor a trial of its partner’s lead asset.

(Reuters) -French pharmaceuticals company Sanofi said on Tuesday it would acquire British private biotechnology firm Vicebio ...

Thermo Fisher will expand use of the Sanofi site to meet the demand from pharma and biotech customers for U.S. manufacturing capacity.

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

"Epilepsy Pipeline Analysis"DelveInsight's,“Epilepsy - Pipeline Insight, 2025” report provides comprehensive insights about 75+ companies and 90+ pipeline drugs in Epilepsy pipeline landscape ...